The current price of INMD is $13.40 — it has decreased by 0.04% since the previous close. Data as of Nov 6, 2026.
INMD is down 1.40% over the past week, down 4.15% over the past month and down 7.13% over the past year. The price is below its 200-day moving average of $14.33.
Analysts' average 12-month price target for INMD is $19.00, which implies 41.84% upside from the current price. Individual estimates range from $19.00 to $19.00.
Of the 5 analysts covering InMode Ltd., 5 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
InMode Ltd. has a market capitalization of $770.8M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, InMode Ltd. posted earnings of $0.35 per share against an estimate of $0.346, beating expectations by 1.16%. Upcoming reports are listed in the earnings calendar.
InMode Ltd. reported revenue of $95.59M in its most recent quarter, which has decreased by 0.01% compared with the same quarter a year earlier. Analysts had expected $93.05M.
InMode Ltd. has not paid any dividends over the past year.
Companies most comparable to InMode Ltd. include Align Technology, Inc., Establishment Labs Holdings Inc., SkinHealth Systems Inc. and AirSculpt Technologies, Inc.
In the latest trading session INMD moved between $13.16 and $13.41, a range of 1.87% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of InMode Ltd. shows a sell rating today and a sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for InMode Ltd. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks INMD has traded between $12.72 and $16.67. The current price is 19.65% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.